Cerebrolysin® is safe and well tolerated!
The experience with Cerebrolysin® during many years of clinical application, the information from post-marketing surveillance studies, and the safety data from double-blind, placebo-controlled clinical trials indicate an extremely high degree of safety (e.g. significat reduction of mortality in CASTA study1).
According to EMA classification, Cerebrolysin® is in the
1 Heiss 2012, Stroke. 43:630-636.